
Cognivia Releases New Patient Adherence Solution
Compl-AI©™ aims to predict the risk of patient nonadherence and dropout.
Cognivia has announced the launch of its latest solution: Compl-AI©™.
Compl-AI is a predictive tool that helps clinical trial sponsors with patient recruitment and engagement strategies. The new tool scores patient behavior at screening using machine learning. The Compl-AI patient behavior score enables individualized patient engagement strategies. Beyond clinical research, Compl-AI offers healthcare providers an approach to tailor and adjust their patient support for better treatment adherence.
Using Compl-AI, sponsors can detect the risk of non-compliance and drop out risk before the start and monitor it over the course of their clinical trial.
Reference
Cognivia expands its portfolio of predictive solutions introducing Compl-AI©™, an innovative solution that predicts the risk of patient nonadherence & dropout. (2023, May 23). Cision PR Newswire.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.






.png)



.png)



.png)
.png)
